Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Enzolytics Inc
ENZC
Healthcare
Biotechnology
Enzolytics, Inc. is a drug development company. The Company is engaged in the commercialization of its proteins and monoclonal antibodies for the treatment of debilitating infectious diseases. Its patented and clinically tested compound, ITV-1 (Immune Therapeutic Vaccine-1), is a suspension of Inactivated Pepsin Fraction (IPF) for the treatment of human immunodeficiency virus/ acquired...
immunodeficiency syndrome (HIV/AIDS). It has a technology for producing fully human monoclonal antibodies (mAbs) against infectious diseases which is being employed to produce monoclonal antibody therapeutics for treating the Coronavirus (SARS-CoV-2), HIV-1 and the Feline Leukemia virus. The Company also plans to produce mAbs targeting many other viruses, including HIV-2, Influenza A and B, H1N1 influenza, Respiratory syncytial virus (RSV), Small-Pox, Ebola Virus, Tetanus, Diphtheria, HTLV-1/2, Rabies, Herpes zoster, Varicella zoster, Anthrax, Mason-Pfizer monkey virus (MPMV) and Visna virus (VISNA).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCPK:ENZC)
New Post
View:
Posts & Comments
Threaded Posts
(271)
•••
whytestocks
X
Post by
whytestocks
on Jul 31, 2024 5:46pm
Enzolytics, Inc. and the Bulgarian Academy of Sciences Initi
News; $ENZC Enzolytics, Inc. and the Bulgarian Academy of Sciences Initiate a Cooperative Program Primarily Focusing on Applied and Strategic Research in Immunology for Cancer and HIV/AIDS
...more
(1)
•••
Williaminvestor
X
Post by
Williaminvestor
on May 15, 2023 9:55am
Undervalued Biotech Stocks to Watch
Undervalued Biotech Stocks to Watch After Enzolytics’ (OTC:$ENZC) 300% Run: $RMED, $SPPI, $HALB, $VXRT https://www.marketwatch.com/press-release/undervalued-biotech-stocks-to-watch-after-enzolytics
...more
Redefining Neuroprotection: Revive’s Approach to Treating Brain Injury from Nerve Agents
posted Dec 03, 2024 9:00am by
Revive Therapeutics Ltd
-
|
Evaluating Bucillamine as a potential treatment for nerve agent exposure, in partnership with Defence R&D Canada – Suffield Research Centre (“DRDC”), an agency of the Canadian Department of National Defence. The DRDC is investigating pharmacological compounds, including Bucillamine, that can mitigate nerve agent induced brain injury. ...read more
(0)
•••
Djritzz
X
Post by
Djritzz
on Feb 17, 2022 9:55am
On track for product on shelves by march!!
https://www.digitaljournal.com/pr/enzolytics-ipf-immune-is-the-perfect-choice-for-people-with-weakened-immune-systems#ixzz7L5P5KBMX
(4)
•••
AviseAnalytics
X
Post by
AviseAnalytics
on Jun 11, 2021 8:39am
$ELZC 5 Reasons Why Enzolytics is a Compelling Choice!
5 Reasons Why Enzolytics is a Compelling Choice! 5 Reasons Why Enzolytics is a Compelling Choice!
(27)
•••
Goldnboy1
X
Post by
Goldnboy1
on Mar 16, 2021 10:16am
Next ENZC minus the selloff
$apc.v Get long. You'll be happy you did. Some biggggg $$$ circling it!!
(15)
•••
Towser7
X
Post by
Towser7
on Feb 05, 2021 10:42pm
Seriously?
Nobody is posting on this? Fascinating company with a promising HIV drug.
(0)
•••
Dayngerdabs
X
Post by
Dayngerdabs
on Jan 13, 2021 2:31am
ENZC and BSSP
$ENZC if you follow ENZC , You need to follow and look into $BSSP , these companies have the same board of directors , and bssp submitted for an FDA approval. Look into NDA 1168 , immunotherapy drug
...more
(0)
•••
Dayngerdabs
X
Post by
Dayngerdabs
on Jan 10, 2021 7:44pm
ENZC and BSSP
$ENZC if you follow ENZC , You need to follow and look into $BSSP , these companies have the same board of directors , and bssp submitted for an FDA approval. Look into NDA 1168 , immunotherapy drug
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Unique Battery Metals opportunity in Quebec
Discover Options Trading Strategies to Minimize your Tax Burden
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Debt-Free Cannabis Company Set for Next Stage of Growth
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Rig Count Soars as Utilization Surpasses Industry Averages
Learn How this Company is Disrupting Point-of-Care Testing